HNGE

Hinge Health CEO Dan Perez Focused on Efficient Growth One Year After IPO

Published: Jun 1, 2026   |  Read Original Article ↗

Article Summary

HOLD
  • Hinge Health (NASDAQ: HINGE) reported a major executive shake-up, with CEO Dan Perez focusing on efficient growth strategy one year after Hinge Health's IPO.
  • The company's valuation has remained relatively stable, though shares have declined slightly as investors reassess valuation expectations.
  • Analysts note that Hinge Health remains focused on operational efficiency rather than valuation metrics.
  • Investors may see the company as a potential growth catalyst, but the companyâ €focused on efficiency over valuation metricsâ€remains a high-growth opportunity.
Free users see 3 BUY signals per day. Premium unlocks all of them, plus instant email alerts. See Plans
Growth Stock Metric Rating
HNGE Rating
66.2
HOLD

Growth Stock Scoring Breakdown

METRIC VALUE WEIGHT ANALYSIS
Sales Growth TTM ? 49.8% 25% 95.0 ptsOutstanding (49.8%) - Very strong
EPS Growth Next 5Y ? 15.1% 25% 50.0 ptsMeets Minimum (15.1%) - Passes screener
Target Price Upside ? 16.6% 20% 60.0 ptsModerate Upside (16.6%) - Target: $70.73 vs Current: $60.67
Gross Margin % ? 80.8% 15% 100.0 ptsExceptional (80.8%) - Strong pricing power
Drawdown from 52-Wk High ? -2.4% 15% 20.0 ptsBarely a Dip (-2.4%) - Near recent highs
Disclaimer: This rating is for informational purposes only and is not financial advice. All data sourced from Finviz. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.

HNGE - Daily Chart

Loading chart data...
Powered by Finviz & ApexCharts

About HNGE

Healthcare Health Information Services 1,437 employees San Francisco, United States
  • Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology.
  • It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.
  • The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device.
  • It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Get BUY-rated growth stocks delivered after market close.